A review on targeting nanoparticles for breast cancer

HGJ Alqaraghuli, S Kashanian… - Current pharmaceutical …, 2019 - ingentaconnect.com
Chemotherapeutic agents have been used extensively in breast cancer remedy. However,
most anticancer drugs cannot differentiate between cancer cells and normal cells, leading to …

Amphiphilic polymeric nanoparticles encapsulating curcumin: Antioxidant, anti-inflammatory and biocompatibility studies

GM Pontes-Quero, L Benito-Garzón, JP Cano… - Materials Science and …, 2021 - Elsevier
Oxidative stress and inflammation are two related processes common to many diseases.
Curcumin is a natural compound with both antioxidant and anti-inflammatory properties …

Mitochondria targeting and destabilizing hyaluronic acid derivative-based nanoparticles for the delivery of lapatinib to triple-negative breast cancer

SY Lee, HJ Cho - Biomacromolecules, 2018 - ACS Publications
CD44 receptor and mitochondria targeting hyaluronic acid-d-α-tocopherol succinate-(4-
carboxybutyl) triphenyl phosphonium bromide (HA-TS-TPP)-based nanoparticles (NPs) …

Modulation of inflammatory mediators by polymeric nanoparticles loaded with anti-inflammatory drugs

GM Pontes-Quero, L Benito-Garzón, J Pérez Cano… - Pharmaceutics, 2021 - mdpi.com
The first-line treatment of osteoarthritis is based on anti-inflammatory drugs, the most
currently used being nonsteroidal anti-inflammatory drugs, selective cyclooxygenase 2 …

Triarylphosphonium compounds as effective vectors for mitochondria-targeted delivery systems: decoration strategies and prospects for clinical application

TN Pashirova, AV Nemtarev, EB Souto, EB Souto… - Uspehi …, 2023 - journals.rcsi.science
Mitochondrial dysfunctions lead to the emergence and development of a large number of
diseases. The present review gives the first systematic survey of various aspects of studies …

Affinity-based polymers provide long-term immunotherapeutic drug delivery across particle size ranges optimal for macrophage targeting

NA Rohner, LN Purdue, HA von Recum - Journal of pharmaceutical …, 2021 - Elsevier
Drug delivery to specific arms of the immune system can be technically challenging to
provide prolonged drug release while limiting off-target toxicity given the limitations of …

Anticancer Activity of HER2-targeting CPP-PTEN-THP Chimeric Proteins

E Pioquinto-Avila, AO González-Cruz… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: Protein phosphatase and tensin homolog (PTEN) is a tumor suppressor
protein with potential to be a new biotechnological drug for PTEN-deficient cancer treatment …

[PDF][PDF] Триарилфосфониевые соединения—эффективные векторы для митохондриально-направленных систем доставки: стратегии декорирования и …

ТН Паширова, АВ Немтарев… - Russian Chemical …, 2023 - researchgate.net
Митохондриальные дисфункции приводят к возникновению и развитию большого
числа заболеваний. В настоящем обзоре впервые обобщены данные по различным …

Nanotechnology and Drug Delivery

GA Islan, S Martin-Saldaña, MT Chevalier… - ADME Processes in …, 2018 - Springer
Nanotechnology could be defined as the manipulation of atoms and molecules to design,
develop, and apply natural and artificial structures and/or devices with special purposes or …

[PDF][PDF] Producción de la proteína quimérica TAT-PTEN-LTV y su efecto citotóxico biodirigido a células de cáncer de mama HER2-positivo

AO González Cruz - 2022 - eprints.uanl.mx
El cáncer es uno de los mayores problemas de salud a nivel mundial, se estima que en
2020 provocó 9.9 millones de defunciones, y se enlistan 5 tipos de cáncer responsables del …